Jin Medical International Ltd. (ZJYL)
(Delayed Data from NSDQ)
$2.51 USD
0.00 (0.00%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $2.51 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Jin Medical International Ltd falls in the month of September.
All items in Millions except Per Share data.
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 17 | 7 | -99,999 | -99,999 | -99,999 |
Receivables | 8 | 4 | NA | NA | NA |
Notes Receivable | 0 | 0 | NA | NA | NA |
Inventories | 5 | 7 | NA | NA | NA |
Other Current Assets | 1 | 1 | NA | NA | NA |
Total Current Assets | 31 | 19 | NA | NA | NA |
Net Property & Equipment | 1 | 2 | NA | NA | NA |
Investments & Advances | 0 | 0 | NA | NA | NA |
Other Non-Current Assets | 0 | 0 | NA | NA | NA |
Deferred Charges | 0 | 0 | NA | NA | NA |
Intangibles | 0 | 0 | NA | NA | NA |
Deposits & Other Assets | 0 | 0 | NA | NA | NA |
Total Assets | 33 | 21 | NA | NA | NA |
Liabilities & Shareholders Equity | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 |
---|---|---|---|---|---|
Notes Payable | 4 | 0 | NA | NA | NA |
Accounts Payable | 3 | 4 | NA | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | NA |
Current Portion Capital Leases | 0 | 0 | NA | NA | NA |
Accrued Expenses | 0 | 0 | NA | NA | NA |
Income Taxes Payable | 0 | 0 | NA | NA | NA |
Other Current Liabilities | 1 | 1 | NA | NA | NA |
Total Current Liabilities | 9 | 6 | NA | NA | NA |
Mortgages | 0 | 0 | NA | NA | NA |
Deferred Taxes/Income | 0 | 0 | NA | NA | NA |
Convertible Debt | 0 | 0 | NA | NA | NA |
Long-Term Debt | 0 | 0 | NA | NA | NA |
Non-Current Capital Leases | 0 | 0 | NA | NA | NA |
Other Non-Current Liabilities | 0 | 0 | NA | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | NA |
Total Liabilities | 9 | 6 | NA | NA | NA |
Shareholders Equity | 9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | NA |
Common Stock (Par) | 0 | 0 | NA | NA | NA |
Capital Surplus | 6 | 0 | NA | NA | NA |
Retained Earnings | 17 | 14 | NA | NA | NA |
Other Equity | 1 | 1 | NA | NA | NA |
Treasury Stock | 0 | 0 | NA | NA | NA |
Total Shareholder's Equity | 24 | 15 | NA | NA | NA |
Total Liabilities & Shareholder's Equity | 33 | 21 | NA | NA | NA |
Total Common Equity | 24 | 15 | 0 | 0 | 0 |
Shares Outstanding | 155.00 | NA | NA | NA | NA |
Book Value Per Share | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Jin Medical International Ltd falls in the month of September.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 26 | -99,999 | 17 | -99,999 |
Receivables | NA | 5 | NA | 8 | NA |
Notes Receivable | NA | NA | NA | 0 | NA |
Inventories | NA | 5 | NA | 5 | NA |
Other Current Assets | NA | 2 | NA | 1 | NA |
Total Current Assets | NA | 38 | NA | 31 | NA |
Net Property & Equipment | NA | 1 | NA | 1 | NA |
Investments & Advances | NA | NA | NA | 0 | NA |
Other Non-Current Assets | NA | NA | NA | 0 | NA |
Deferred Charges | NA | 0 | NA | 0 | NA |
Intangibles | NA | 1 | NA | 0 | NA |
Deposits & Other Assets | NA | NA | NA | 0 | NA |
Total Assets | NA | 41 | NA | 33 | NA |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 10 | NA | 4 | NA |
Accounts Payable | NA | 3 | NA | 3 | NA |
Current Portion Long-Term Debt | NA | NA | NA | 0 | NA |
Current Portion Capital Leases | NA | NA | NA | 0 | NA |
Accrued Expenses | NA | 1 | NA | 0 | NA |
Income Taxes Payable | NA | 1 | NA | 0 | NA |
Other Current Liabilities | NA | 1 | NA | 1 | NA |
Total Current Liabilities | NA | 15 | NA | 9 | NA |
Mortgages | NA | NA | NA | 0 | NA |
Deferred Taxes/Income | NA | NA | NA | 0 | NA |
Convertible Debt | NA | NA | NA | 0 | NA |
Long-Term Debt | NA | NA | NA | 0 | NA |
Non-Current Capital Leases | NA | NA | NA | 0 | NA |
Other Non-Current Liabilities | NA | NA | 0 | NA | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | NA |
Total Liabilities | NA | 15 | NA | 9 | NA |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | NA |
Common Stock (Par) | NA | 0 | NA | 0 | NA |
Capital Surplus | NA | 7 | NA | 6 | NA |
Retained Earnings | NA | 18 | NA | 17 | NA |
Other Equity | NA | 1 | NA | 1 | NA |
Treasury Stock | NA | NA | NA | 0 | NA |
Total Shareholder's Equity | NA | 26 | NA | 24 | NA |
Total Liabilities & Shareholder's Equity | NA | 41 | NA | 33 | NA |
Total Common Equity | 0 | 100,025 | 0 | 24 | 0 |
Shares Outstanding | 155.00 | 155.00 | 155.00 | 155.00 | 155.00 |
Book Value Per Share | 0.00 | 645.32 | 0.00 | 0.15 | 0.00 |